Armistice Capital’s Vera Therapeutics VERA Stock Holding History

Armistice Capital’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.9M	Buy	300,000 +1,836	+0.6%	+$68.4K	0.16%	91
2026 Q1	$12M	Sell	298,164 -355,632	-54%	-$15.3M	0.21%	82
2025 Q4	$33.1M	Buy	653,796 +117,796	+22%	+$4.18M	0.39%	44
2025 Q3	$15.6M	Buy	536,000 +400,000	+294%	+$9.25M	0.23%	70
2025 Q2	$3.2M	Sell	136,000 -164,000	-55%	-$3.69M	0.06%	118
2025 Q1	$7.21M	Buy	300,000 +121,717	+68%	+$3.91M	0.11%	102
2024 Q4	$7.54M	Buy	+178,283	New	+$7.89M	0.1%	109

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital's VERA Position: Q2 2026 in Review

Armistice Capital increased its Vera Therapeutics (VERA) stake by 0.62% in Q2 2026, buying an estimated $68.4K and bringing the position to 300,000 shares worth $12.9M. The position accounts for 0.16% of the portfolio, ranked #91.

Armistice Capital first reported a position in VERA in Q4 2024 and has held it in 7 quarters since. The position peaked at $33.1M in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Armistice Capital held 300,000 shares of Vera Therapeutics worth $12.9M as of Q2 2026.
Armistice Capital bought 1,836 Vera Therapeutics shares in Q2 2026, an estimated $68.4K.
Vera Therapeutics made up 0.16% of Armistice Capital's portfolio in Q2 2026, its #91 holding.
Armistice Capital first reported a position in Vera Therapeutics in Q4 2024 and has held it in 7 quarters since.
Armistice Capital's Vera Therapeutics position peaked at $33.1M in Q4 2025.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.